Skip to main content
. 2017 Jun 23;158(9):2848–2859. doi: 10.1210/en.2017-00213

Figure 3.

Figure 3.

Rosi attenuates 10,12 CLA-induced subcutaneous fat loss. (a) Body weights measured weekly. (b) Food intake measured after 1 and 5 weeks on indicated diets (15 and 19 weeks of HFHS feeding, respectively). (c) Body composition performed at baseline (B; 9 weeks of HFHS feeding), and again after 2 and 5 weeks on the indicated diets and presented as % body fat (left) and lean body mass (right). (d) Excised fat pads weighed at euthanasia. R, Rosi lead-in. n = 8 to 12 mice per group, presented as mean ± standard error of the mean. *P < 0.05 from HFHS control; #P < 0.05 from 10,12 CLA.